• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Putative synaptotagmin-14-like protein (SYT14L)

ACP17168

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17168 Target NameSYT14P1
Target SynonymsSYT14P1; SYT14L; SYT14LP1; SYTDEP; Putative synaptotagmin-14-like protein; Synaptotagmin XIV protein pseudogene 1; Synaptotagmin XIV-derived protein; Synaptotagmin XIV-like proteinFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-188
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ58G82
Background Information
  • Uniprot Id

    Q58G82

  • Target Species

    Human

  • Target Name

    SYT14P1

  • Target Full Name

    Putative synaptotagmin-14-like protein

  • Target Function

    Plays a role in melanocyte differentiation; enhances dendrite outgrowth, melanin content and tyrosinase activity through the modulation of ERK and/or CREB pathways.

  • Target Protein Families

    Synaptotagmin family

  • Target Tissue Specificity

    Expressed in mature peripheral blood neutrophils (at protein level). Expressed in heart, pancreas, liver and skeletal muscle. Expressed in umbilical vein endothelial cells and melanocytes.

  • Target Synonyms

    SYT14P1; SYT14L; SYT14LP1; SYTDEP; Putative synaptotagmin-14-like protein; Synaptotagmin XIV protein pseudogene 1; Synaptotagmin XIV-derived protein; Synaptotagmin XIV-like protein

Inquire Recombinant Human Putative synaptotagmin-14-like protein (SYT14L) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification